Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2013-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_810d32a706f6ad060bcb3ec549f5f83c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e7ee3d444c50e8b229988212c5d77ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e37a67cf0db972130452e1fc9c8f9e63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f51f7a4ceacf9b5771fcfcf8895085a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9b1c9e1bfc8c043fc179fd9bf6b9869 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_154b0a7b4bc0bde11c245fa2aedabf21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc54d04555124650bb3e220997dbf76e |
publicationDate |
2016-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9428577-B2 |
titleOfInvention |
Platelet-derived growth factor B specific antibodies and compositions and uses thereof |
abstract |
The present invention provides antibodies, or antigen-binding fragment thereof, which specifically bind to PDGF-B. The invention further provides a method of obtaining such antibodies and nucleic acids encoding the same. The invention further relates to compositions and therapeutic methods for use of these antibodies for the treatment and/or prevention of PDGF-B mediated diseases, disorders or conditions. |
priorityDate |
2012-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |